{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:45:16Z","timestamp":1790801116662,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T00:00:00Z","timestamp":1499299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics & Neonatology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.pedneo.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T15:45:43Z","timestamp":1499787943000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Effect of bosentan therapy in persistent pulmonary hypertension of the newborn"],"prefix":"10.1016","volume":"59","author":[{"given":"Gunlawadee","family":"Maneenil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anucha","family":"Thatrimontrichai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waricha","family":"Janjindamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supaporn","family":"Dissaneevate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2017.02.003_bib1","first-page":"157","article-title":"Diagnosis and management of persistent pulmonary hypertension of the newborn","volume":"16","author":"Bendapudi","year":"2015","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.pedneo.2017.02.003_bib2","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1542\/neo.16-12-e680","article-title":"Persistent pulmonary hypertension of the newborn","volume":"16","author":"Lakshminrusimha","year":"2015","journal-title":"Neoreviews"},{"issue":"4","key":"10.1016\/j.pedneo.2017.02.003_bib3","first-page":"CD000399","article-title":"Nitric oxide for respiratory failure in infants born at or near term","author":"Finer","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pedneo.2017.02.003_bib4","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/jp.2016.44","article-title":"Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates","volume":"36","author":"Lakshminrusimha","year":"2016","journal-title":"J Perinatol"},{"key":"10.1016\/j.pedneo.2017.02.003_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-2007-994352","article-title":"Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn","volume":"13","author":"Kumar","year":"1996","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.pedneo.2017.02.003_bib6","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.pedneo.2017.02.003_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0009-9236(03)00005-5","article-title":"Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension","volume":"73","author":"Barst","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pedneo.2017.02.003_bib8","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1365-2125.2009.03532.x","article-title":"Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study","volume":"68","author":"Beghetti","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pedneo.2017.02.003_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2165\/00003088-200443150-00003","article-title":"Clinical pharmacology of bosentan, a dual endothelin receptor antagonist","volume":"43","author":"Dingemanse","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pedneo.2017.02.003_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00431-007-0531-y","article-title":"Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan","volume":"167","author":"Goissen","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.pedneo.2017.02.003_bib11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00431-011-1422-9","article-title":"Combination therapy for life-threatening pulmonary hypertension in a premature infant: first report on bosentan use","volume":"170","author":"Radicioni","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.pedneo.2017.02.003_bib12","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1651-2227.2009.01386.x","article-title":"Successful treatment of persistent pulmonary hypertension of the newborn with bosentan","volume":"98","author":"Nakwan","year":"2009","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.pedneo.2017.02.003_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/jp.2011.157","article-title":"A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn","volume":"32","author":"Mohamed","year":"2012","journal-title":"J Perinatol"},{"key":"10.1016\/j.pedneo.2017.02.003_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jpeds.2016.06.078","article-title":"Bosentan as adjunctive therapy for persistent pulmonary hypertension of the newborn: results of the randomized multicenter placebo-controlled exploratory trial","volume":"177","author":"Steinhorn","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.pedneo.2017.02.003_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.semperi.2013.11.004","article-title":"Update on PPHN: mechanisms and treatment","volume":"38","author":"Nair","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.pedneo.2017.02.003_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.prrv.2005.03.005","article-title":"Pulmonary hypertension in the newborn","volume":"6","author":"Greenough","year":"2005","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.pedneo.2017.02.003_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2133\/dmpk.DMPK-10-RG-113","article-title":"Pharmacokinetics of bosentan in routinely treated Japanese pediatric patients with pulmonary arterial hypertension","volume":"26","author":"Taguchi","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pedneo.2017.02.003_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.siny.2006.01.002","article-title":"Blood pressure disorders in the neonate: hypotension and hypertension","volume":"11","author":"Fanaroff","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.pedneo.2017.02.003_bib19","series-title":"Neurology of the newborn","first-page":"403","article-title":"Intracranial hemorrhage: germinal matrix hemorrhage","author":"Volpe","year":"2008"},{"key":"10.1016\/j.pedneo.2017.02.003_bib20","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","article-title":"Bronchopulmonary dysplasia","volume":"163","author":"Jobe","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pedneo.2017.02.003_bib21","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1542\/peds.2005-0523","article-title":"Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study","volume":"117","author":"Baquero","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2017.02.003_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jcrc.2006.01.001","article-title":"Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn","volume":"21","author":"McNamara","year":"2006","journal-title":"J Crit Care"},{"key":"10.1016\/j.pedneo.2017.02.003_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000088192","article-title":"Neonatal persistent pulmonary hypertension treated with milrinone: four case reports","volume":"89","author":"Bassler","year":"2006","journal-title":"Biol Neonate"},{"key":"10.1016\/j.pedneo.2017.02.003_bib24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s13312-013-0263-1","article-title":"Effectiveness and safety of intravenous iloprost for severe persistent pulmonary hypertension of the newborn","volume":"50","author":"Janjindamai","year":"2013","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.pedneo.2017.02.003_bib25","doi-asserted-by":"crossref","first-page":"858154","DOI":"10.1155\/2011\/858154","article-title":"Patient characteristics in persistent pulmonary hypertension of the newborn","volume":"2011","author":"Roofthooft","year":"2011","journal-title":"Pulm Med"},{"key":"10.1016\/j.pedneo.2017.02.003_bib26","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.12669\/pjms.295.3728","article-title":"Risk factors and mortality among newborns with persistent pulmonary hypertension","volume":"29","author":"Razzaq","year":"2013","journal-title":"Pak J Med Sci"}],"container-title":["Pediatrics & Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957217304102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957217304102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:52:41Z","timestamp":1761749561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957217304102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1875957217304102"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2017.02.003","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of bosentan therapy in persistent pulmonary hypertension of the newborn","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}